APPYEA, INC (APYP)
2025-06-30 | 2025-03-31 | 2024-09-30 | 2024-06-30 | |
---|---|---|---|---|
Revenues | 1 | 3 | 1 | 2 |
Cost of sales | 4 | 4 | 2 | 3 |
Gross profit (loss) | -3 | -1 | -1 | -1 |
General and administrative expenses | 97 | 111 | 298 | 205 |
Research and development expenses | 221 | - | 159 | 96 |
Sales and marketing expenses | 32 | 17 | 153 | 103 |
Research and development expenses | - | -6 | - | - |
Operating loss | -353 | -123 | -610 | -405 |
Change in fair value of convertible loans and warrant liability | 358 | -44 | 139 | 716 |
Financial expenses, net | -11 | 1 | - | - |
Other nonoperating expense | - | - | 41 | - |
Loss before income tax benefit | - | -166 | -512 | - |
Financial (expenses) income, net | - | - | - | -130 |
Net profit (loss) | -6 | -166 | -512 | 181 |
Net profit (loss) attributable to appyea inc | -6 | -166 | -512 | 181 |
Basic | - | -0 | - | - |
Diluted | - | -0 | - | - |
Weighted average number of common shares outstanding basic | 534,758,474 | 527,945,974 | 483,923,616 | 453,450,254 |
Weighted average number of common shares outstanding diluted | 534,758,474 | 527,945,974 | 483,923,616 | 453,450,254 |